Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer
Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
Genome Medicine
|
November 2, 2018
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
S Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, et al.
Cancer Discovery
|
July 12, 2022
AACR Project GENIE: 100,000 Cases and Beyond
Trevor J Pugh, Jonathan L Bell, Jeff P Bruce, et al.
International Journal of Molecular Sciences
|
January 28, 2026
The Genetic and Molecular Analyses of Rare Candidate Germline <i>BRIP1/FANCJ</i> Variants Implicated in Hereditary Breast and Ovarian Cancers
Wejdan M Alenezi, Larissa Milano, Caitlin T Fierheller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Stephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
NPJ Vaccines
|
October 21, 2020
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein
Alexander J McAuley, Michael J Kuiper, Peter A Durr, et al.
Frontiers in Immunology
|
June 3, 2022
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Nagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, et al.
Viruses
|
April 23, 2022
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice
Petrus Jansen van Vuren, Alexander J McAuley, Michael J Kuiper, et al.
Genes
|
February 25, 2023
Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing Gene
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, et al.
Nature Communications
|
August 30, 2024
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation
Philip Barbulescu, Chetan K Chana, Matthew K Wong, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer
Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
Genome Medicine
|
November 2, 2018
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
S Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, et al.
Cancer Discovery
|
July 12, 2022
AACR Project GENIE: 100,000 Cases and Beyond
Trevor J Pugh, Jonathan L Bell, Jeff P Bruce, et al.
International Journal of Molecular Sciences
|
January 28, 2026
The Genetic and Molecular Analyses of Rare Candidate Germline <i>BRIP1/FANCJ</i> Variants Implicated in Hereditary Breast and Ovarian Cancers
Wejdan M Alenezi, Larissa Milano, Caitlin T Fierheller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Stephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
NPJ Vaccines
|
October 21, 2020
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein
Alexander J McAuley, Michael J Kuiper, Peter A Durr, et al.
Frontiers in Immunology
|
June 3, 2022
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Nagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, et al.
Viruses
|
April 23, 2022
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice
Petrus Jansen van Vuren, Alexander J McAuley, Michael J Kuiper, et al.
Genes
|
February 25, 2023
Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing Gene
Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, et al.
Nature Communications
|
August 30, 2024
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation
Philip Barbulescu, Chetan K Chana, Matthew K Wong, et al.
Page
of 13